All Episodes

February 5, 2024 31 mins

This episode is sponsored by Acceleration Point.

 Pharma Sessions is hosted by Jonathan Kaskey

In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs. 

Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements. 

Scott encourages experimentation with secure, customized AI tools to improve output. 
He outlines a case study where AI improved data quality and speed of information processing.

Scott and Jonathan ultimately envision a world where AI technologies will help Medical Affairs expand its reach, improve communication, and increase its impact in the medical community.

 00:18 Understanding the Role of AI in Med Affairs

00:46 Guest Introduction: Scott Thompson, Co-CEO of Acceleration Point

03:12 The Evolution of AI in Medical Affairs

04:46 The Impact of AI on Big Data and Medical Affairs

06:03 The Three Buckets of AI Application in Med Affairs

09:53 Overcoming Fear and Resistance to AI

13:12 The Future of AI in Medical Affairs

20:18 Case Study: Successful AI Implementation in a Global Med Affairs Team

30:18 Conclusion and Farewell

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.